DCF — BEARTOOTH BILLINGS CLINIC
Enterprise Value: $-20.4M
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$-20.4M
Enterprise Value
$-6.7M
PV of Cash Flows
$-13.8M
PV of Terminal Value
$-22.2M
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $18.9M | $-1.2M | -6.0% | $-2.0M | $-1.8M |
| Year 2 | $19.5M | $-1.0M | -5.0% | $-1.8M | $-1.5M |
| Year 3 | $20.1M | $-0.8M | -4.0% | $-1.7M | $-1.3M |
| Year 4 | $20.7M | $-0.7M | -4.0% | $-1.6M | $-1.1M |
| Year 5 | $21.3M | $-0.7M | -3.0% | $-1.6M | $-1.0M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $-20.4M. Terminal value accounts for 0% of total EV — consider sensitivity to terminal assumptions.
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$18.4M
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base-0.06623193216767001
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5